BRICS Infectious Immunology Market 2018 Outlooks: Brazil, Russia, India, China, South Africa

GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018″ provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Request your sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=68839

Scope

- Market size data for Infectious Immunology market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology
- Annualized market revenues ($m) data for each of the segments and sub-segments within the five market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Infectious Immunology market in BRICS.
- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Shanghai Kehua Bio-engineering Co., Ltd., Siemens Healthcare, bioMerieux S.A., DiaSorin S.p.A, Qiagen N.V., Transasia Bio-Medicals Ltd., Alere Inc., Beckman Coulter, Inc., Gen-Probe Incorporated, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Trivitron Healthcare Pvt Ltd., Span Diagnostics Ltd., Thermo Fisher Scientific Inc., Tulip Diagnostics (P) Ltd, Cellestis Limited, Chembio Diagnostics, Inc. and Hologic, Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Infectious Immunology competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Buy your report copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=68839

Table Of Contents

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11

2 Introduction 14
2.1 What is This Report About? 14

3 Infectious Immunology in BRICS 15
3.1 Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
3.2 Infectious Immunology, BRICS, Company share (2010-2011) 21

4 Infectious Immunology In Brazil 23
4.1 Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
4.2 Hepatitis Viruses In Brazi 29
4.2.1 Hepatitis Viruses, Brazil, Overall Revenue (2004-2018) 29
4.3 Other Virology In Brazil 31
4.3.1 Other Virology, Brazil, Overall Revenue (2004-2018) 31
4.4 Retroviruses In Brazil 33
4.4.1 Retroviruses, Brazil, Overall Revenue (2004-2018) 33
4.5 Bacteriology In Brazil 35
4.5.1 Bacteriology, Brazil, Overall Revenue (2004-2018) 35
4.6 Infectious Immunology Rapid Tests In Brazil 37
4.6.1 Infectious Immunology Rapid Tests, Brazil, Overall Revenue (2004-2018) 37
4.7 Infectious Immunology, Brazil, Distribution Share (2010-2011) 41
4.8 Infectious Immunology, Brazil, Company Share (2010-2011) 42

5 Infectious Immunology In Russian Federation 44
5.1 Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 44
5.2 Hepatitis Viruses In Russian Federation 50
5.2.1 Hepatitis Viruses, Russian Federation, Overall Revenue (2004-2018) 50
5.3 Retroviruses In Russian Federation 52
5.2.2 Retroviruses, Russian Federation, Overall Revenue (2004-2018) 52
5.3 Other Virology In Russian Federation 54
5.3.1 Other Virology, Russian Federation, Overall Revenue (2004-2018) 54
5.4 Bacteriology In Russian zFederation 56
5.4.1 Bacteriology, Russian Federation, Overall Revenue (2004-2018) 56
5.5 Infectious Immunology Rapid Tests In Russian Federation 58
5.5.1 Infectious Immunology Rapid Tests, Russian Federation, Overall Revenue (2004-2018) 58
5.6 Infectious Immunology, Russian Federation, Distribution Share (2010-2011) 62
5.7 Infectious Immunology, Russian Federation, Company Share (2010-2011) 63

6 Infectious Immunology In India 65
6.1 Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 65
6.2 Infectious Immunology Rapid Tests In India 71
6.2.1 Infectious Immunology Rapid Tests, India, Overall Revenue (2004-2018) 71
6.3 Hepatitis Viruses In India 75
6.3.1 Hepatitis Viruses, India, Overall Revenue (2004-2018) 75
6.4 Retroviruses In India 77
6.4.1 Retroviruses, India, Overall Revenue (2004-2018) 77
6.5 Bacteriology In India 79
6.5.1 Bacteriology, India, Overall Revenue (2004-2018) 79
6.6 Other Virology In India 81
6.6.1 Other Virology, India, Overall Revenue (2004-2018) 81
6.7 Infectious Immunology, India, Distribution Share (2010-2011) 83
6.8 Infectious Immunology, India, Company Share (2010-2011) 84

7 Infectious Immunology In China 86
7.1 Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 86
7.2 Retroviruses In China 92
7.2.1 Retroviruses, China, Overall Revenue (2004-2018) 92
7.3 Hepatitis Viruses In China 94
7.3.1 Hepatitis Viruses, China, Overall Revenue (2004-2018) 94
7.4 Other Virology In China 96
7.4.1 Other Virology, China, Overall Revenue (2004-2018) 96
7.5 Bacteriology In China 98
7.5.1 Bacteriology, China, Overall Revenue (2004-2018) 98
7.6 Infectious Immunology Rapid Tests In China 100
7.6.1 Infectious Immunology Rapid Tests, China, Overall Revenue (2004-2018) 100
7.7 Infectious Immunology, China, Distribution Share (2010-2011) 104
7.8 Infectious Immunology, China, Company Share (2010-2011) 105

8 Infectious Immunology In South Africa 107
8.1 Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107
8.2 Retroviruses In South Africa 113
8.2.1 Retroviruses, South Africa, Overall Revenue (2004-2018) 113
8.3 Hepatitis Viruses In South Africa 115
8.3.1 Hepatitis Viruses, South Africa, Overall Revenue (2004-2018) 115
8.4 Other Virology In South Africa 117
8.4.1 Other Virology, South Africa, Overall Revenue (2004-2018) 117
8.5 Bacteriology In South Africa 119
8.5.1 Bacteriology, South Africa, Overall Revenue (2004-2018) 119
8.6 Infectious Immunology Rapid Tests In South Africa 121
8.6.1 Infectious Immunology Rapid Tests, South Africa, Overall Revenue (2004-2018) 121
8.7 Infectious Immunology, South Africa, Distribution Share (2010-2011) 125
8.8 Infectious Immunology, South Africa, Company Share (2010-2011) 126

9 Overview of Key Companies in BRICS Infectious Immunology Market 128
9.1 Abbott Laboratories 128
9.1.1 Company Overview 128
9.1.2 Share in the BRICS Infectious Immunology Market 129
9.2 F. Hoffmann-La Roche Ltd. 130
9.2.1 Company Overview 130
9.2.2 Share in the BRICS Infectious Immunology Market 131
9.3 Shanghai Kehua Bio-engineering Co., Ltd. 132
9.3.1 Company Overview 132
9.3.2 Share in the BRICS Infectious Immunology Market 132
9.4 Siemens Healthcare 133
9.4.1 Company Overview 133
9.4.2 Share in the BRICS Infectious Immunology Market 134
9.5 bioMerieux S.A. 135
9.5.1 Company Overview 135
9.5.2 Share in the BRICS Infectious Immunology Market 136
9.6 DiaSorin S.p.A 137
9.6.1 Company Overview 137
9.6.2 Share in the BRICS Infectious Immunology Market 138
9.7 Qiagen N.V. 139
9.7.1 Company Overview 139
9.7.2 Share in the BRICS Infectious Immunology Market 140
9.8 Transasia Bio-Medicals Ltd. 141
9.8.1 Company Overview 141
9.8.2 Share in the BRICS Infectious Immunology Market 141
9.9 Alere Inc. 142
9.9.1 Company Overview 142
9.9.2 Share in the BRICS Infectious Immunology Market 143

9.10 Beckman Coulter, Inc. 144
9.10.1 Company Overview 144
9.10.2 Share in the BRICS Infectious Immunology Market 145
9.11 Gen-Probe Incorporated 146
9.11.1 Company Overview 146
9.11.2 Share in the BRICS Infectious Immunology Market 147
9.12 Becton, Dickinson and Company 148
9.12.1 Company Overview 148
9.12.2 Share in the BRICS Infectious Immunology Market 149
9.13 Bio-Rad Laboratories, Inc. 150
9.13.1 Company Overview 150
9.13.2 Share in the BRICS Infectious Immunology Market 151
9.14 PerkinElmer, Inc. 152
9.14.1 Company Overview 152
9.14.2 Share in the BRICS Infectious Immunology Market 153
9.15 Trivitron Healthcare Pvt Ltd. 154
9.15.1 Company Overview 154
9.15.2 Share in the BRICS Infectious Immunology Market 154
9.16 Span Diagnostics Ltd. 155
9.16.1 Company Overview 155
9.16.2 Share in the BRICS Infectious Immunology Market 155
9.17 Thermo Fisher Scientific Inc. 156
9.17.1 Company Overview 156
9.17.2 Share in the BRICS Infectious Immunology Market 157
9.18 Tulip Diagnostics (P) Ltd 158
9.18.1 Company Overview 158
9.18.2 Share in the BRICS Infectious Immunology Market 158
9.19 Cellestis Limited 159
9.19.1 Company Overview 159
9.19.2 Share in the BRICS Infectious Immunology Market 159
9.20 Chembio Diagnostics, Inc. 160
9.20.1 Company Overview 160
9.20.2 Share in the BRICS Infectious Immunology Market 160
9.21 Hologic, Inc. 161
9.21.1 Company Overview 161
9.21.2 Share in the BRICS Infectious Immunology Market 161

10 Appendix 162
10.1 Definitions of Markets Covered in the Report 163
10.1.1 Infectious Immunology 163
10.2 Research Methodology 164
10.3 Secondary Research 164
10.4 Primary Research 165
10.5 Models 165
10.6 Forecasts 166
10.7 Expert Panels 166
10.8 GlobalData Consulting 166
10.9 Currency Conversion 167
10.10 Contact Us 167
10.11 Disclaimer 167